-
Symbol
-
ALLO on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock
-
Latest Disclosed Ownership
-
12.4M shares
-
Security Ownership
-
5.8%
Arie Belldegrun, M.D. ownership in Allogene Therapeutics, Inc. Common Stock (ALLO)
2025-02-13 - Arie Belldegrun, M.D. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12.4M shares of Allogene Therapeutics, Inc. Common Stock (ALLO).
This represents 5.8% percent ownership of the company.